Stereotactic ablative radiotherapy for oligometastatic breast cancer in elderly patients

被引：1
|
作者：
Morales-Orue, Ignacio [1 ,2 ,3 ]
Zafra-Martin, Juan [3 ]
Garcia, Laura [3 ]
Chicas-Sett, Rodolfo [3 ]
Castilla-Martinez, Juan [3 ]
Auxiliadora Cabezon, Maria [3 ]
Burgos, Javier [4 ]
Lloret, Marta [3 ]
Lara, Pedro C. [4 ,5 ]
机构：
[1] Punta Europa Hosp, Dept Radiat Oncol, Carretera Getares S-N, Algeciras 11207, Spain
[2] Punta Europa Hosp, Dept Med Oncol, Algeciras, Spain
[3] Dr Negrin Univ Hosp Gran Canaria, Dept Radiat Oncol, Las Palmas Gran Canaria, Spain
[4] San Roque Univ Hosp, Dept Oncol, Las Palmas Gran Canaria, Spain
[5] Fernando Pessoa Canarias Univ, Fac Hlth Sci, Las Palmas Gran Canaria, Spain
来源：
TRANSLATIONAL CANCER RESEARCH | 2020年 / 9卷
关键词：
Stereotactic ablative radiotherapy (SABR); elderly; oligometastatic; radiotherapy; breast; BODY RADIATION-THERAPY; QUALITY-OF-LIFE; BRAIN METASTASES; COMBINATION CHEMOTHERAPY; INTERNATIONAL SOCIETY; GERIATRIC ASSESSMENT; FOLLOW-UP; RADIOSURGERY; ONCOLOGY; SBRT;
D O I：
10.21037/tcr.2019.08.29
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Breast cancer (BC) is the principal cause of cancer-related death in women. Metastatic patients are usually treated with a systemic therapy, but clinical results are limited. Oligometastatic subjects can benefit from high-precision radiotherapy techniques to potentially achieve a complete response. Currently, there is limited evidence of stereotactic ablative radiotherapy (SABR) treatments in elderly oligometastatic cancer patients. A review of the medical literature was performed in PubMed database to assess the current role of SABR in the treatment of breast oligometastases in elderly patients. SABR represents a feasible and safe therapeutic approach in oligometastatic elderly BC patients. Further studies are required to establish the optimum patient selection and treatment scheme.
引用
收藏
页码：S197 / S206
页数：10
相关论文
共 50 条
  • [31] Stereotactic ablative body radiotherapy (SABR) for NSCLC oligometastatic patients: feasibility and outcomes
    Campisi, M. C.
    Navarria, P.
    Ascolese, A. M.
    De Rose, F.
    Alloisio, M.
    Infante, M.
    Palumbo, V.
    Reggiori, G.
    Tomatis, S.
    Scorsetti, M.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S119 - S119
  • [32] VMAT Stereotactic Ablative Radiotherapy for oligometastatic patients: role of FDG PET/CT
    BORGHES, S., I
    Gasperi, C.
    Terziani, F.
    Curion, A. S.
    Rampini, A.
    Pernici, P.
    Bertocci, S.
    Gennari, P. G.
    Iermano, C.
    De Majo, R.
    Losardo, P. L.
    Tucci, E.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1227 - S1228
  • [33] Role of consolidative stereotactic ablative radiotherapy in patients with oligometastatic non-small cell lung cancer
    Ricardi, Umberto
    Levra, Niccolo Giaj
    Badellino, Serena
    Alongi, Filippo
    JOURNAL OF THORACIC DISEASE, 2017, 9 (08) : 2235 - 2237
  • [34] Radiotherapy in patients with oligometastatic breast cancer
    Krug, David
    Fabian, Alexander
    Pyschny, Florian
    Blanck, Oliver
    Dellas, Kathrin
    Maass, Nicolai
    Dunst, Juergen
    GYNAKOLOGE, 2019, 52 (12): : 918 - 925
  • [35] Oligometastatic cancer in elderly patients: the "blitzkrieg" radiotherapy approach: SBRT in oligometastatic elderly patients
    Lancia, Andrea
    Ingrosso, Gianluca
    Carosi, Alessandra
    Bottero, Marta
    Cancelli, Alessandro
    Turturici, Irene
    Ponti, Elisabetta
    Santoni, Riccardo
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2019, 31 (01) : 109 - 114
  • [36] Extracranial Stereotactic Body Radiotherapy in Oligometastatic or Oligoprogressive Breast Cancer
    Weykamp, Fabian
    Koenig, Laila
    Seidensaal, Katharina
    Forster, Tobias
    Hoegen, Philipp
    Akbaba, Sati
    Mende, Stephan
    Welte, Stefan E.
    Deutsch, Thomas M.
    Schneeweiss, Andreas
    Debus, Juergen
    Hoerner-Rieber, Juliane
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [37] Second Chance for Cure: Stereotactic Ablative Radiotherapy in Oligometastatic Disease
    Salim, Nidal
    Tumanova, Kristina
    Popodko, Alexey
    Libson, Evgeny
    JCO GLOBAL ONCOLOGY, 2024, 10
  • [38] Outcomes of stereotactic body radiotherapy on oligometastatic and oligoprogressive breast cancer
    Armstrong, Shreya
    Makris, Andreas
    Belessiotis-Richards, Katherine
    Abdul-Latif, Mohammed
    Ostler, Peter
    Shah, Nihal
    Miles, David
    Tsang, Yat Man
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S484 - S486
  • [39] Stereotactic body radiotherapy in extracranial oligometastatic or oligoprogressive breast cancer
    Weykamp, F.
    Koenig, L.
    Seidensaal, K.
    Forster, T.
    Hoegen, P.
    Akbaba, S.
    Susko, M.
    Schneeweiss, A.
    Debus, J.
    Hoerner-Rieber, J.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S516 - S517
  • [40] CyberKnife Stereotactic Ablative Radiotherapy for Recurrent or Oligometastatic Gynecological Cancers
    Kataria, Tejinder
    Naga, Pushpa
    Banerjee, Susovan
    Gupta, Deepak
    Narang, Kushal
    Tayal, Manoj
    Bisht, Shyam Singh
    SOUTH ASIAN JOURNAL OF CANCER, 2021, 10 (02) : 107 - 111
12345